BioSpace News Archive

TriLink BioTechnologies, a Maravai™ LifeSciences company and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries.

Anixa Biosciences, Inc. today announced its participation in the Sidoti Micro-Cap Virtual Conference, taking place May 8-9, 2024.

NeoGenomics, Inc., a leading provider of oncology testing and global contract research services, announced its first-quarter results for the period ended March 31, 2024.

908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook.

Inspire Medical Systems, Inc. announced that its management team will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024.

X4 Pharmaceuticals, Inc. today announced that it will be reporting financial results for the first quarter ended March 31, 2024 and providing corporate updates on Tuesday, May 7, 2024.

Panbela Therapeutics, Inc. announced that an abstract for eflornithine, an inhibitor of polyamine synthesis, has been accepted for an oral presentation at the Digestive Disease Week conference, which will be held May 18-21, 2024.

Biora Therapeutics, Inc today announced completion of dosing for the multiple-ascending dose cohorts for its clinical study of BT-600.

Senti Biosciences, Inc. today announced the publication of preclinical data demonstrating the ability of natural killer (NK) cells engineered with multi-input Gene Circuits to selectively target and eliminate leukemic cells, including both blasts and leukemic stem cells, while sparing healthy stem cells. The data was published in Cell Reports on April 25, 2024.

Curis, Inc. today announced that the Company will release its first quarter 2024 financial results on Tuesday, May 7, 2024 , at 8:00 a.m. ET.